Corpus 1,276 assessed · 1,177 scored · 644 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: partial ✕ Southern Medical University ✕ 1 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Reducing language barriers, promoting information absorption, and communication using fanyi. PMID 39039634	Chin Med J (Engl)	2024	67	L1 67/100
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100

Reducing language barriers, promoting information absorption, and communication using fanyi.

PMID 39039634 · Chin Med J (Engl) · 2024

L1 67/100

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

PMID 38897205 · Cell Rep Med · 2024

L1 72/100